S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

DMK DMK Pharmaceuticals Corporation

0.232

0.00 (0.00%)

Last Updated: 19:00:00

Delayed by 15 minutes

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

DMK Pharmaceuticals (NASDAQ:DMK)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more DMK Pharmaceuticals Charts.

DMK Pharmaceuticals (NASDAQ:DMK)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more DMK Pharmaceuticals Charts.

DMK Pharmaceuticals Corporation News

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Thursday 21 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 7 February 2024 (4 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Tuesday 6 February 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 5 February 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 31 January 2024 (4 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 23 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 23 January 2024 (4 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Wednesday 3 January 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 3 January 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 3 January 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 21 December 2023 (5 months ago) • Edgar (US Regulatory)

DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI
Thursday 21 December 2023 (5 months ago) • GlobeNewswire Inc.

More DMK Pharmaceuticals Corporation News Articles

Vontobel Financial Produ...

Apartment Investment & M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions